Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Syndax Pharmaceuticals Q4 EPS $(0.62) Beats $(0.65) Estimate

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.65) by 4.62 percent. This is a 134.25 percent decrease over earnings of $1.81 per share
byBill Haddad
February 28, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.65) by 4.62 percent. This is a 134.25 percent decrease over earnings of $1.81 per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Sportsman’s Warehouse And 3 Other Penny Stocks Insiders Are Buying

By Lisa Levin
September 29, 9:08 AM
The Dow Jones closed higher by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BCOV